Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers
Clinical trial NCT07598968 · COMPLETED
Trial details
- NCT number
- NCT07598968
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-18
- Primary completion
- 2023-07-12
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.